vindesine has been researched along with Multiple Myeloma in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Chen, YL; Ma, XH; Qiu, ZY; Ren, CA; Wang, YF; Xu, WJ | 1 |
| Kunihiko, M; Mariko, Y; Shinichiro, O; Yasuo, I; Yusuke, T; Yutaka, H | 1 |
| Handa, H; Irisawa, H; Komatsumoto, S; Matsushima, T; Murakami, H; Nojima, Y; Tsukamoto, N | 1 |
| Meng, H; Qian, W; Shao, K; Yang, C; Yang, X; Ye, X; Zhou, Y | 1 |
| Durie, BG; Salmon, SE | 1 |
| Halie, MR; Marrink, J; Nieweg, HO; Ockhuizen, T; Piersma, H; van Dobbenburgh, OA | 1 |
| Halie, MR; Houwen, B; Marrink, J; Nieweg, HO; Ockhuizen, T; van Dobbenburgh, OA | 1 |
| Halie, MR; Houwen, B; Marrink, J; Nieweg, HO; Ockhuizen, T; Piersma, H; Van Dobbenburgh, OA | 1 |
| Halie, MR; Houwen, B; Jurjens, H; Marrink, J; Nieweg, HO; Van Dobbenburgh, OA | 1 |
| Alexanian, R; Bodey, GP; Yap, BS | 1 |
| Ferrazzi, E; Fiorentino, MV; Galligioni, E; Pappagallo, GL; Salvagno, L; Segati, R; Vinante, O; Zagonel, V | 1 |
| Houwen, B; Marrink, J; Nieweg, HO; Ockhuizen, T | 1 |
| Kobayashi, K; Matano, S; Nakamura, S; Yoshida, T | 1 |
| Benboubker, L; Colombat, P; Combe, M; Delain, M; Goupille, P; Lamagnère, JP; Linassier, C; Luthier, F; Petitdidier, C; Reisenleiter, M | 1 |
| Imamura, Y; Kosaka, M; Mikuni, C; Mori, M; Nishinarita, S; Sezaki, T; Takagi, T; Takatsuki, K; Tsuchiya, J; Yawata, Y | 1 |
| Mizoguchi, H; Ohasi, Y; Takaku, F; Togawa, A; Toyama, K; Urabe, A | 1 |
| Manoharan, A | 1 |
| Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C | 1 |
| Hirashima, K; Hotta, T; Kashimura, M; Ogawa, N; Sawamura, M; Sezaki, T; Takagi, T; Tsuchiya, J | 1 |
| Abe, T; Hasegawa, Y; Kobayashi, T; Nagasawa, T; Sato, Y; Yoda, Y | 1 |
| Kanoh, T | 1 |
| Monasch, E; Pegels, HG; van der Lelie, H; von dem Borne, AE | 1 |
| Casara, D; Chiarion Sileni, V; De Besi, P; Fiorentino, MV; Frizzarin, M; Paccagnella, A; Salvagno, L | 1 |
2 review(s) available for vindesine and Multiple Myeloma
| Article | Year |
|---|---|
The current status and future prospects of treatment for multiple myeloma.
Topics: Acute Kidney Injury; Altretamine; Anemia; Bacterial Infections; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Hypercalcemia; Interferons; Kidney Failure, Chronic; Melphalan; Meningeal Neoplasms; Multiple Myeloma; Spinal Cord Compression; Vinblastine; Vincristine; Vindesine | 1982 |
Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiotonic Agents; Combined Modality Therapy; Cyclophosphamide; Diuretics; Female; Heart Failure; Humans; Immunologic Factors; Interferon Type I; Melphalan; Middle Aged; Multiple Myeloma; Plasmapheresis; Prednisolone; Recombinant Proteins; Vindesine | 1992 |
6 trial(s) available for vindesine and Multiple Myeloma
| Article | Year |
|---|---|
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Regression Analysis; Survival Analysis; Treatment Outcome; Vincristine; Vindesine | 1994 |
Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Japan; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prospective Studies; Remission Induction; Survival Rate; Vindesine | 1994 |
[Clinical evaluation of rhG-CSF in patients with neutropenia induced by chemotherapy for multiple myeloma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vindesine | 2000 |
Gentle yet effective treatment for elderly patients with refractory or relapsing multiple myeloma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Multiple Myeloma; Prednisolone; Recurrence; Treatment Outcome; Vincristine; Vindesine | 2000 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Clinical benefits of lenograstim in patients with neutropenia due to chemotherapy for multiple myeloma (MM).
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Double-Blind Method; Female; Granulocyte Colony-Stimulating Factor; Humans; Japan; Lenograstim; Male; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Prednisolone; Recombinant Proteins; Statistics, Nonparametric; Treatment Outcome; Vindesine | 2001 |
16 other study(ies) available for vindesine and Multiple Myeloma
| Article | Year |
|---|---|
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
[Effect of BD Regimen Combined with Cyclophosphamide and Pirarubicin in Treatment of Relapse/Refractory Multiple Myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lomustine; Multiple Myeloma; Neoplasm Recurrence, Local; Vindesine | 2016 |
Thalidomide for the treatment of leptomeningeal multiple myeloma.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunoglobulin G; Melphalan; Meningeal Neoplasms; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Thalidomide; Vindesine | 2006 |
[Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma].
Topics: Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Drug Administration Schedule; Female; Humans; Melphalan; Multiple Myeloma; Neovascularization, Pathologic; Nitrosourea Compounds; Plasmacytoma; Prednisolone; Prednisone; Tomography, X-Ray Computed; Vindesine | 2006 |
Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Harringtonines; Homoharringtonine; Humans; Male; Melphalan; Multiple Myeloma; Oxides; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Vincristine; Vindesine | 2007 |
Multiple myeloma with high tumour mass. Treatment with high-dose methylprednisolone, cyclophosphamide and vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Cyclophosphamide; Female; Humans; Immunoglobulins; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Vinblastine; Vindesine | 1984 |
Progress report on vindesine treatment of melphalan-resistant multiple myeloma.
Topics: Antineoplastic Agents; Drug Resistance; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone; Vinblastine; Vindesine | 1983 |
Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vinblastine; Vindesine | 1984 |
Plasma spermidine concentrations as early indication of response to therapy in human myeloma.
Topics: Antineoplastic Agents; Humans; Multiple Myeloma; Prednisone; Prognosis; Spermidine; Time Factors; Vinblastine; Vindesine | 1983 |
Prednisone pulse therapy for refractory myeloma.
Topics: Bone Marrow; Doxorubicin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Plasma Cells; Prednisone; Vinblastine; Vincristine; Vindesine | 1983 |
Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Digestive System; Drug Evaluation; Female; Humans; Leukemia, Lymphoid; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycosis Fungoides; Nervous System; Plasmacytoma; Vinblastine; Vindesine | 1982 |
Vindesine therapy in melphalan-resistant multiple myeloma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Vinblastine; Vindesine | 1981 |
[Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 7; Cyclophosphamide; Eosinophilia; Female; Humans; Melphalan; Multiple Myeloma; Myelodysplastic Syndromes; Prednisolone; Translocation, Genetic; Vindesine | 1994 |
Fatal paralytic ileus following vindesine chemotherapy in a patient with myeloma-associated amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Intestinal Pseudo-Obstruction; Multiple Myeloma; Prednisolone; Vindesine | 1989 |
Vindesine in refractory multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Prognosis; Vincristine; Vindesine | 1986 |
Vindesine in plasma cell tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Resistance; Female; Humans; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Prednisone; Vindesine | 1985 |